Košík

0504625 - ÚEB 2020 RIV GR eng J - Článek v odborném periodiku
Kubczak, M. - Szustka, A. - Błoński, J. Z. - Gucký, T. - Misiewicz, M. - Kryštof, Vladimír - Robak, Z. - Rogalińska, M.
Dose and drug changes in chronic lymphocytic leukemia cell response in vitro: A comparison of standard therapy regimens with two novel cyclin‑dependent kinase inhibitors.
Molecular Medicine Reports. Roč. 19, č. 5 (2019), s. 3593-3603. ISSN 1791-2997. E-ISSN 1791-3004
Grant CEP: GA MŠMT(CZ) LO1204; GA ČR(CZ) GA15-15264S
Institucionální podpora: RVO:61389030
Klíčová slova: Alkylator * Anticancer agents * Apoptosis * Chronic lymphocytic leukemia * Cyclin-dependent kinase inhibitor * In vitro cell incubations * Monoclonal antibody * Necrosis * Viability
Obor OECD: Hematology
Impakt faktor: 2.100, rok: 2019
Způsob publikování: Open access
http://doi.org/10.3892/mmr.2019.10007
Trvalý link: http://hdl.handle.net/11104/0296211